GRP
ALGS icon

Global Retirement Partners’s Aligos Therapeutics ALGS Stock Holding History

Global Retirement Partners’s Portfolio ALGS Stock Details ALGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$3.73K Sell
400
-400
-50% -$3.77K ﹤0.01% 3536
2025
Q3 		$7.84K Buy
+800
New +$7.31K ﹤0.01% 2789

Other funds holding ALGS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Global Retirement Partners's ALGS Position: Q4 2025 in Review

Global Retirement Partners reduced its Aligos Therapeutics (ALGS) stake by 50% in Q4 2025, selling an estimated $3.77K and leaving 400 shares worth $3.73K. The position accounts for ﹤0.01% of the portfolio, ranked #3536.

Global Retirement Partners first reported a position in ALGS in Q3 2025 and has held it in 2 quarters since. The position peaked at $7.84K in Q3 2025. 40 funds tracked by Wall St. Rank hold ALGS as of Q4 2025.

  • Global Retirement Partners held 400 shares of Aligos Therapeutics worth $3.73K as of Q4 2025.
  • Global Retirement Partners sold 400 Aligos Therapeutics shares in Q4 2025, an estimated $3.77K.
  • Aligos Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3536 holding.
  • Global Retirement Partners first reported a position in Aligos Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • Global Retirement Partners's Aligos Therapeutics position peaked at $7.84K in Q3 2025.
  • 40 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.